
Credit Suisse bondholders sue
FT News Briefing
00:00
Legal Challenges to Mifepristone and Its Impact on Pharma Innovation
This chapter explores the recent court ruling that overturned the FDA approval of the abortion pill Mifepristone, raising concerns about the future of pharmaceutical innovation in the U.S. Experts discuss the broader implications of eroding the FDA's authority and the potential deterrent effects on drug investment and research and development.
Play episode from 05:50
Transcript


